{"id":"W3080135677","doi":"10.1200/jco.2009.27.15_suppl.3510","title":"A phase I and pharmacological study of MK-1775, a Wee1 tyrosine kinase inhibitor, in both monotherapy and in combination with gemcitabine, cisplatin, or carboplatin in patients with advanced solid tumors","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Gemcitabine; Tolerability; Neutropenia; Carboplatin; Internal medicine; Pharmacodynamics; Pharmacology; Oncology; Cancer; Pharmacokinetics; Cisplatin; Chemotherapy; Adverse effect","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001202506,0.0001894732,0.001534654,0.0003876207,0.00001485589,0.000005403643,0.000065183,0.0002098975,0.00001197027],"category_scores_gemma":[0.0006371287,0.0001212945,0.00004444087,0.0004556947,0.0001471917,0.0001333072,0.00002079196,0.0009814511,9.769354e-8],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000189191,"about_ca_system_score_gemma":0.0005765485,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003359478,"about_ca_topic_score_gemma":0.0006018771,"domain_scores_codex":[0.9967995,0.0003827646,0.001969926,0.0002724577,0.0003541853,0.0002211371],"domain_scores_gemma":[0.9978269,0.0005008709,0.001159243,0.000102994,0.0002148795,0.0001951531],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.2140466,0.05435169,0.5387912,0.00003581233,0.0001371986,0.003265078,0.001188655,0.0004679401,0.005840395,0.000005988712,0.00002620249,0.1818431],"study_design_scores_gemma":[0.1840475,0.157146,0.6572677,0.0003311106,0.00009364899,0.00005646713,0.0002171047,0.0004383911,0.0002499385,0.00002711178,0.00002588077,0.00009908395],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9979182,0.000223003,0.00003206921,0.0005939666,0.00007999054,0.001100613,0.00000285279,0.000004942396,0.00004433435],"genre_scores_gemma":[0.9979414,0.0001673688,0.001345335,0.0004654966,0.0000456378,0.00001160462,0.000002826178,0.00001564115,0.000004689951],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1817441,"threshold_uncertainty_score":0.4946245,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03808350545614243,"score_gpt":0.4159918490186893,"score_spread":0.3779083435625469,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}